US Patent 7220767 Pharmaceutical formulations containing zolmitriptan
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Alan Roy Dearn0
John Simon Summers0
Sarah Louise Williamson0
Trevor John Coomber0
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+186 characters)
Article
Patent abstract
A pharmaceutical formulation of the 5HT1-agonist, zolmitriptan, for use in intranasal administration. The formulation is useful in treating migraine and related disorders.
Edits on 21 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07220767 Pharmaceutical formulations containing zolmitriptan US Patent 7220767 Pharmaceutical formulations containing zolmitriptan
Infobox
Patent Number
072207670
Patent Number
72207670
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
072207670
Date of Patent
May 22, 2007
0Patent Application Number
108549590
Date Filed
May 27, 2004
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 21 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07220767 Pharmaceutical formulations containing zolmitriptan
Infobox
Is a
Patent jurisdiction
Patent number
07220767
Date of patent
May 22, 2007
Patent application number
10854959
Date Filed
May 27, 2004
Patent primary examiner
Find more entities like US Patent 7220767 Pharmaceutical formulations containing zolmitriptan
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
